WallStreetZenWallStreetZen

How to Buy Kyverna Therapeutics Stock

Kyverna Therapeutics Inc

Kyverna Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients suffering from autoimmune diseases.

Kyverna Therapeutics stock last closed at $14.00, down 4.11% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Kyverna Therapeutics stock is currently +14.19% from its 52-week low of $12.26, and -60.07% from its 52-week high of $35.06.

There are currently 43.12M shares of KYTX outstanding. The market value of KYTX is $603.61M. In the past 24 hours, 217,579 KYTX shares were traded.

How to Buy Kyverna Therapeutics Stock

Wondering how to invest in Kyverna Therapeutics stock? Here's how.
  1. Choose where to buy Kyverna Therapeutics stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Kyverna Therapeutics stock.
  2. Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Fund your investment account: Select your payment method and add your information.
  4. Evaluate Kyverna Therapeutics stock: The Kyverna Therapeutics ticker symbol is KYTX. Is Kyverna Therapeutics stock a good investment? Should you buy shares of KYTX? How do KYTX's underlying business fundamentals look? Do top analysts think Kyverna Therapeutics is a good buy? Why has KYTX's stock price moved recently? (Hint: Our stock research tools can help you understand if KYTX is a good stock to buy).
  5. Execute your KYTX purchase: Decide if you will purchase KYTX shares at the current market price or use a limit order to buy KYTX stock at a particular price.
  6. Watch your investment in KYTX: Create a watchlist to track your investment in Kyverna Therapeutics shares.

Step 1: Choose where to buy Kyverna Therapeutics stock

You need an online brokerage account to access the NASDAQ market and buy KYTX stock.

A brokerage account allows you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our experience, eToro is the best stock brokerage. Here's why:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to global markets: From Technology to Energy, New York to Hong Kong — you can fill your portfolio with stocks from the world's top stock exchanges.
  • Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your stock purchase by creating an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've picked your brokerage, the next step is to fill out some personal details so you are able to buy KYTX today.

How to Start a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to start a new brokerage account.
  1. Send your application by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your investment account

Now that you have filled out your info on a good online stock trading app, you need to deposit funds:

Check out the tutorial below if you need help depositing money into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Kyverna Therapeutics stock

After you have figured out the best place to buy Kyverna Therapeutics stock, it's very important to analyze their stock before you buy, so you truly understand the risk as well as the upside.

Kyverna Therapeutics Numbers

KYTX Price
$14.00
1w %
-8.2%
1y %
N/A
5y %
N/A
P/E
-0.16x
P/B
-4.59x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$60.37M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$603.61M
Next Earnings
N/A
Next Dividend
N/A

Fundamentals of Kyverna Therapeutics

WallStreetZen was created to help everyday investors do more in-depth fundamental analysis in less time.

You can view all of the due diligence checks on KYTX's stock page.

Is KYTX stock overvalued?

Investors use many financial metrics, analyses, models, and charts to gauge KYTX's fair value.

You can access additional valuation analysis on KYTX's stock here.

A look at KYTX Cashflows and Balance Sheet

Signs that KYTX is financially healthy:

  • There are more short-term assets than long-term liabilities on the KYTX balance sheet.
  • KYTX has $58.11M in cash and short term investments. This is sufficient to cover its annual cash burn of $53.03M.
  • There are more short-term assets than short-term liabilities on the KYTX balance sheet.
  • KYTX has cash burn of 53031000. It has enough cash and short-term investments to cover this for at least one year.

Signs that KYTX is not financially healthy:

  • KYTX debt to equity ratio of -0.2 is negative.
  • Total KYTX debt is still negative.

Is it a good time to buy KYTX stock, according to Wall Street analysts?

Out of 2 sell side analysts who research KYTX, the consensus analyst rating on Kyverna Therapeutics is a Strong Buy

Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.

You can dive deeper into what analysts are forecasting on the Kyverna Therapeutics stock forecast page.

KYTX Technical Indicators

SMA10
14.59
SMA20
16.83
SMA50
22.28
SMA100
N/A
SMA200
N/A
MACD
-2.53
MACD Signal
-2.52
MACD Histogram
0
RSI
33.8
Stochastic %K
20.2
Stochastic %D
13.72
StochRSI %K
66.11
StochRSI %D
47.39

KYTX Earnings

Last year, KYTX revenue was $0.00. Over the last two year, KYTX's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 31.46%.

You can research KYTX's earnings and revenue performance here.

Who is buying/selling KYTX?

In the past year, executives and large shareholders at KYTX have bought more shares than they have sold.

Bain Capital Life Sciences Investors LLC, 10% Owner of KYTX, was the latest KYTX insider to buy. They bought $9,900,000.00 worth of KYTX shares on Feb 12, 2024.

Get more info about who owns KYTX stock here.

Does KYTX provide a stable income stream?

No, Kyverna Therapeutics doesn't provide an income stream by paying out dividends.

KYTX Social Trading Data

One of the major reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Execute your KYTX purchase

You have two primary order types:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are usually the best for newer investors.
  • Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at a specific price, place a limit order.

Hit the Open Trade button and your broker will execute your order.

If you want additional help with investing in stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Watch your investment in KYTX

Now that you own some KYTX stock, you'll want to keep up with your new shares.

Add KYTX to a watchlist to track the most important metrics related to your KYTX stock.

KYTX Feed

How to Buy Stock in Kyverna Therapeutics

To summarize, here are the 6 steps for buying Kyverna Therapeutics stock:

  1. Choose where to buy Kyverna Therapeutics stock
  2. Open a brokerage account
  3. Fund your investment account
  4. Evaluate Kyverna Therapeutics stock
  5. Execute your KYTX purchase
  6. Watch your investment in KYTX

If you require a place to buy stocks, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get notifications regarding your new investment in Kyverna Therapeutics, click below.

NASDAQ: KYTX
$14.00-0.60 (-4.11%)
Updated May 10, 2024
Open eToro Account
NASDAQ: KYTX
$14.00-0.60 (-4.11%)
Updated May 10, 2024
Open eToro Account

FAQ

How much does it cost to buy one Kyverna Therapeutics share?

As of May 10, 2024, it costs $14.00 to buy one share of Kyverna Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $7, you can buy 0.5 shares of KYTX.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Kyverna Therapeutics stock?

According to 2 Wall Street analysts who monitor Kyverna Therapeutics, their consensus recommendation is to buy Kyverna Therapeutics stock.

What is the best way to buy Kyverna Therapeutics stock?

One way to place an order for Kyverna Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.